Font Size:
a
A
A
Keyword [Macular Edema secondary to Central Retinal Vein Occlusion]
Result: 1 - 8 | Page: 1 of 1
1.
0.3mg Ranibizumab Versus 0.5mg Ranibizumab For Macular Edema Secondary To Central Retinal Vein Occlusion: A Systematic Review
2.
Clinical Observation Of Intravitreal Injection Of Lucentis On The Treatment For Macular Edema Secondary To Central Retinal Vein Occlusion
3.
Observation Of Clinical Treatment Of Macular Edema Secondary To Central Retinal Vein Occlusion By Intravitreal Ranibizumab And Laser Photocoagulation
4.
Clinical Study Of Intravitreal Injection Of Conbercept In The Treatment Of Macular Edema Secondary To Central Retinal Vein Occlusion
5.
Comparison Of The Clinical Effect And Visual Acuity Prognosis Related Factors Of Ranibizumab For Macular Edema Secondary To Central Retinal Vein Occlusion In Different Ages
6.
Therapeutic Effect Of Anti-VEGF Drugs Combined With Dexamethasone Intravitreal Implant On Macular Edema Secondary To Central Retinal Vein Occlusion In Young People
7.
Treatment Study On Macular Edema Secondary To Central Retinal Vein Occlusion By Intravitreal Injection Of Ranibizumab Or Dexamethasone Intravitreal Implant
8.
Correlation Between The Concentration Of Some Cytokines In The Aqueous Humor With The Relative Hemorrhage Area And The Central Retinal Thickness Of Patients With Macular Edema Secondary To Central Retinal Vein Occlusion
<<First
<Prev Next>
Last>>
Jump to
